Results 21 to 30 of about 125,713 (396)

COVID-19 in persons with chronic myeloid leukaemia

open access: yesLeukemia, 2020
We studied by questionnaire 530 subjects with chronic myeloid leukaemia (CML) in Hubei Province during the recent SARS-CoV-2 epidemic. Five developed confirmed ( N  = 4) or probable COVID-19 ( N  = 1).
Weiming Li   +41 more
semanticscholar   +1 more source

A Ten Year Descriptive Study of Adult Leukaemia at Al-Jomhori Teaching Hospital in Sana'a, Yemen [PDF]

open access: yesYemeni Journal for Medical Sciences, 2014
Background: There is scarcity of data of the epidemiology of leukaemia in Arab countries including Yemen. Understanding patterns of leukaemia underpins epidemiology and can provide insight into disease etiology.
Jameel Al-Ghazaly   +4 more
doaj   +2 more sources

Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells

open access: yesBritish Journal of Haematology, 2020
There is currently no biomarker that reliably predicts treatment‐free remission (TFR) in chronic myeloid leukaemia (CML). We characterised effector and suppressor immune responses at the time of tyrosine kinase inhibitor (TKI) cessation in patients from ...
Yazad D. Irani   +9 more
semanticscholar   +1 more source

Chronic myeloid leukaemia in megakaryocytic crisis [PDF]

open access: bronzeBritish Journal of Haematology, 2002
Sumathi Ranjitkumar, Robert Lindeman
openalex   +4 more sources

A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease

open access: yesLeukemia, 2020
In chronic-phase chronic myeloid leukaemia (CP-CML), residual BCR-ABL1 + leukaemia stem cells are responsible for disease persistence despite TKI. Based on in vitro data, CHOICES (CHlorOquine and Imatinib Combination to Eliminate Stem cells) was an ...
Gillian Horne   +22 more
semanticscholar   +1 more source

Chronic myeloid leukaemia with lymphosarcoma [PDF]

open access: yesJournal of Clinical Pathology, 1963
The clinical and pathological features of two patients with chronic myeloid leukaemia who died from lymphosarcoma are described. Both had been treated with busulphan which, at the time of development of lymphosarcoma and at death, appeared to be controlling the leukaemia satisfactorily.
J. S. Howell, A. G. W. Whitfield
openaire   +2 more sources

Role of the bone morphogenic protein pathway in developmental haemopoiesis and leukaemogenesis [PDF]

open access: yes, 2016
Myeloid leukaemias share the common characteristics of being stem cell-derived clonal diseases, characterised by excessive proliferation of one or more myeloid lineage.
Toofan, Parto, Wheadon, Helen
core   +1 more source

The chronic myeloid leukemia stem cell: stemming the tide of persistence [PDF]

open access: yes, 2017
Chronic myeloid leukaemia (CML) is caused by the acquisition of the tyrosine kinase BCR-ABL1 in a haemopoietic stem cell (HSC), transforming it into a leukaemic stem cell (LSC) that self-renews, proliferates and differentiates to give rise to a ...
Holyoake, Tessa L., Vetrie, David
core   +1 more source

Key environmental stress biomarker candidates for the optimisation of chemotherapy treatment of leukaemia [PDF]

open access: yes, 2014
The impact of fluctuations of environmental parameters such as oxygen and starvation on the evolution of leukaemia is analysed in the current review.
Brito Dos Santos, Susana   +7 more
core   +1 more source

Concurrence of chronic lymphocytic leukaemia/small lymphocytic lymphoma and acute myeloid leukaemia in a bone marrow biopsy

open access: yesPolish Journal of Pathology, 2020
The association of small lymphocytic lymphoma/chronic lymphocytic leukaemia (CLL) with different malignancies has been reported in the literature. Also the occurrence of a second haematological disease has been described, more frequently as a secondary ...
Stefano Licci
doaj   +1 more source

Home - About - Disclaimer - Privacy